Krystal Biotech, Inc. (KRYS) Investment Research Dashboard
About Krystal Biotech, Inc. (KRYS) stock analysis
Get live KRYS stock price $351.82, comprehensive Krystal Biotech, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time KRYS stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is curr...
Company Information
- CEO
- Krish S. Krishnan
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 295
Contact Information
- Website
- https://www.krystalbio.com
- Address
- 2100 Wharton Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 47.0)
✓ Lower volatility stock (Beta: 0.50) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Krystal Biotech, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Krystal Biotech, Inc.
- ⚠Investors should consider how Krystal Biotech, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 47.0) requires strong growth to justify
Market Cap
10.37B
P/E Ratio (TTM)
47.03
Beta
0.50
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare KRYS with peer companies:
- Price
- $115.07+0.00% (1D)
- Market cap
- 6.73B
- Price
- $52.73-0.30% (1D)
- Market cap
- 8.79B
- Price
- $85.53-0.08% (1D)
- Market cap
- 12.05B
- Price
- $46.73+0.41% (1D)
- Market cap
- 4.51B
- Price
- $70.50+0.00% (1D)
- Market cap
- 7.43B
- Price
- $55.50+1.54% (1D)
- Market cap
- 8.01B
- Price
- $75.80-1.33% (1D)
- Market cap
- 6.29B
- Price
- $135.56-0.40% (1D)
- Market cap
- 8.72B
- Price
- $131.05-0.79% (1D)
- Market cap
- 5.80B
- Price
- $55.75-0.52% (1D)
- Market cap
- 8.53B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- -0.1%
- NASDAQ
- -0.1%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.